Chargement en cours...
A Phase II Study of Pegylated Interferon Alfa-2b (PEG-Intron®) in Children with Diffuse Intrinsic Pontine Glioma (DIPG)
BACKGROUND: Interferon-alpha is a cytokine with demonstrated activity in patients with supratentorial gliomas, but the ideal dose and schedule of administration is unknown. Studies suggest low-dose continuous exposure is more efficacious than intermittent high doses. We performed a Phase II study of...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3290731/ https://ncbi.nlm.nih.gov/pubmed/22086404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26659 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|